- €2.47bn
- €2.11bn
- €3.87bn
- 53
- 92
- 41
- 69
R2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,550 | 2,432 | 3,213 | 5,677 | 3,873 |
Cost of Revenue | |||||
Gross Profit | 340 | -1,727 | 2,531 | 2,457 | 564 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,469 | 4,326 | 696 | 3,677 | 3,548 |
Operating Profit | 80.7 | -1,893 | 2,517 | 2,000 | 325 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 46.4 | -1,999 | 2,426 | 2,135 | 297 |
Provision for Income Taxes | |||||
Net Income After Taxes | 27.3 | -1,891 | 2,134 | 1,508 | 210 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 88.9 | -1,715 | 2,945 | 1,508 | 210 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 88.9 | -1,715 | 2,945 | 1,508 | 210 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.115 | -3.7 | 1.84 | 7.91 | 1.21 |
Dividends per Share |